Cargando…

Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer

BACKGROUND: Higher consumption of coffee and tea has been associated with improved health outcomes in the general population and improved breast cancer (BC) prognosis. This study investigated patterns of coffee and tea consumption and association with patient‐reported outcomes (PROs) and clinical ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Soldato, Davide, Havas, Julie, Crane, Tracy E., Presti, Daniele, Lapidari, Pietro, Rassy, Nathalie, Pistilli, Barbara, Martin, Elise, Del Mastro, Lucia, Martin, Anne‐Laure, Jacquet, Alexandra, Coutant, Charles, Cottu, Paul, Merimeche, Asma, Lerebours, Florence, Tredan, Olivier, Vanlemmens, Laurence, André, Fabrice, Vaz‐Luis, Ines, Di Meglio, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541449/
https://www.ncbi.nlm.nih.gov/pubmed/35913436
http://dx.doi.org/10.1002/cncr.34401
_version_ 1784803927419518976
author Soldato, Davide
Havas, Julie
Crane, Tracy E.
Presti, Daniele
Lapidari, Pietro
Rassy, Nathalie
Pistilli, Barbara
Martin, Elise
Del Mastro, Lucia
Martin, Anne‐Laure
Jacquet, Alexandra
Coutant, Charles
Cottu, Paul
Merimeche, Asma
Lerebours, Florence
Tredan, Olivier
Vanlemmens, Laurence
André, Fabrice
Vaz‐Luis, Ines
Di Meglio, Antonio
author_facet Soldato, Davide
Havas, Julie
Crane, Tracy E.
Presti, Daniele
Lapidari, Pietro
Rassy, Nathalie
Pistilli, Barbara
Martin, Elise
Del Mastro, Lucia
Martin, Anne‐Laure
Jacquet, Alexandra
Coutant, Charles
Cottu, Paul
Merimeche, Asma
Lerebours, Florence
Tredan, Olivier
Vanlemmens, Laurence
André, Fabrice
Vaz‐Luis, Ines
Di Meglio, Antonio
author_sort Soldato, Davide
collection PubMed
description BACKGROUND: Higher consumption of coffee and tea has been associated with improved health outcomes in the general population and improved breast cancer (BC) prognosis. This study investigated patterns of coffee and tea consumption and association with patient‐reported outcomes (PROs) and clinical outcomes among survivors of BC. METHODS: The authors included survivors of stage I–III BC enrolled in the CANTO cohort (NCT01993498) that provided post‐treatment assessment of coffee and tea consumption from years 1 to 4 after diagnosis. Group‐based trajectory modeling clustered patients according to daily consumption of coffee and tea. Multivariable mixed models and Cox models examined associations between consumption, PROs and clinical outcomes. RESULTS: Among 3788 patients, the authors identified four stable patterns of consumption: “Low” (25.8%), “Moderate” (37.6%), “High” (25.3%), and “Very high” (11.3%), corresponding to <1, 2, 3, and ≥ 4 cups of coffee and/or tea per day. Patients in the “Very high” group (vs. “Low”), were more likely to be younger, smokers, with higher monthly income and education. PROs and survival outcomes were similar across the four groups. CONCLUSIONS: Over one in three survivors of BC reported high or very high consumption of coffee and/or tea. The authors found no association between higher consumption of coffee and/or tea, worse PROs and clinical outcomes.
format Online
Article
Text
id pubmed-9541449
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95414492022-10-14 Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer Soldato, Davide Havas, Julie Crane, Tracy E. Presti, Daniele Lapidari, Pietro Rassy, Nathalie Pistilli, Barbara Martin, Elise Del Mastro, Lucia Martin, Anne‐Laure Jacquet, Alexandra Coutant, Charles Cottu, Paul Merimeche, Asma Lerebours, Florence Tredan, Olivier Vanlemmens, Laurence André, Fabrice Vaz‐Luis, Ines Di Meglio, Antonio Cancer Original Articles BACKGROUND: Higher consumption of coffee and tea has been associated with improved health outcomes in the general population and improved breast cancer (BC) prognosis. This study investigated patterns of coffee and tea consumption and association with patient‐reported outcomes (PROs) and clinical outcomes among survivors of BC. METHODS: The authors included survivors of stage I–III BC enrolled in the CANTO cohort (NCT01993498) that provided post‐treatment assessment of coffee and tea consumption from years 1 to 4 after diagnosis. Group‐based trajectory modeling clustered patients according to daily consumption of coffee and tea. Multivariable mixed models and Cox models examined associations between consumption, PROs and clinical outcomes. RESULTS: Among 3788 patients, the authors identified four stable patterns of consumption: “Low” (25.8%), “Moderate” (37.6%), “High” (25.3%), and “Very high” (11.3%), corresponding to <1, 2, 3, and ≥ 4 cups of coffee and/or tea per day. Patients in the “Very high” group (vs. “Low”), were more likely to be younger, smokers, with higher monthly income and education. PROs and survival outcomes were similar across the four groups. CONCLUSIONS: Over one in three survivors of BC reported high or very high consumption of coffee and/or tea. The authors found no association between higher consumption of coffee and/or tea, worse PROs and clinical outcomes. John Wiley and Sons Inc. 2022-08-01 2022-10-01 /pmc/articles/PMC9541449/ /pubmed/35913436 http://dx.doi.org/10.1002/cncr.34401 Text en © 2022 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Soldato, Davide
Havas, Julie
Crane, Tracy E.
Presti, Daniele
Lapidari, Pietro
Rassy, Nathalie
Pistilli, Barbara
Martin, Elise
Del Mastro, Lucia
Martin, Anne‐Laure
Jacquet, Alexandra
Coutant, Charles
Cottu, Paul
Merimeche, Asma
Lerebours, Florence
Tredan, Olivier
Vanlemmens, Laurence
André, Fabrice
Vaz‐Luis, Ines
Di Meglio, Antonio
Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer
title Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer
title_full Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer
title_fullStr Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer
title_full_unstemmed Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer
title_short Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer
title_sort coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541449/
https://www.ncbi.nlm.nih.gov/pubmed/35913436
http://dx.doi.org/10.1002/cncr.34401
work_keys_str_mv AT soldatodavide coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT havasjulie coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT cranetracye coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT prestidaniele coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT lapidaripietro coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT rassynathalie coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT pistillibarbara coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT martinelise coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT delmastrolucia coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT martinannelaure coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT jacquetalexandra coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT coutantcharles coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT cottupaul coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT merimecheasma coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT lereboursflorence coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT tredanolivier coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT vanlemmenslaurence coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT andrefabrice coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT vazluisines coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer
AT dimeglioantonio coffeeandteaconsumptionpatientreportedandclinicaloutcomesinalongitudinalstudyofpatientswithbreastcancer